最新报道：According to BBX Crypto Concept Stock Information, global listed companies continue to invest in crypto assets, with investments and strategic investments exceeding $200 million disclosed yesterday, according to a comprehensive disclosure from Bijie.com and ME. Medical technology company Scilex's innovative stock-for-Bitcoin trading model became a hot topic that day, with European and Asian companies also actively expanding their digital asset businesses. BTC Allocation Updates: Scilex Holding Company (NASDAQ: SCLX) signed an agreement with institutional investors to exchange 12.5 million common shares (valued at $200 million) of its subsidiary, Semnur Pharmaceuticals, for an equivalent value in Bitcoin. The transaction price is $16 per share, and settlement is expected to be completed today. Capital B (Euronext: ALCPB) completed a €1.2 million (approximately $1.3 million) private placement at €1.70 per share. The funds will be used to acquire approximately 10 Bitcoins, potentially increasing its total holdings to 2,810 Bitcoins. Strategic Investment and Ecosystem Development - Jiufang Zhitou Holdings (HKEX: 09636): Through its wholly-owned subsidiary, it subscribed to shares in EX.IO, a licensed virtual asset trading platform in Hong Kong. EX.IO's platform received a virtual asset trading license from the Hong Kong Securities and Futures Commission in December 2024. This move aims to advance the overseas strategic development of its digital asset business. Listed companies are showing innovative trends in crypto asset allocation strategies. Scilex's model of directly acquiring Bitcoin through stock swaps offers institutions a new non-cash asset allocation path. Asian companies are also investing in compliant trading platforms to build digital asset infrastructure ecosystems.